keyword
Keywords antidepressant and hormone the...

antidepressant and hormone therapy interactions

https://read.qxmd.com/read/38551874/-pharmacotherapies-for-insomnia
#1
JOURNAL ARTICLE
Marie-Françoise Vecchierini, Damien Léger
PHARMACOTHERAPIES FOR INSOMNIA. The first line of treatment in adult chronic insomnia is cognitive behavioral therapy (CBT). However, its difficult accessibility limited its use and medications are still often prescribed. Considering the drugs with marketing authorization, Z-drugs (zolpidem and zopiclone) if taken at the right hour and dosage promote sleep initiation and have less deleterious effects than benzodiazepines, especially the long-acting ones which should be avoided. This class of drugs cannot be prescribed longer than 28 days...
March 2024: La Revue du Praticien
https://read.qxmd.com/read/38312240/exposure-to-prescribed-medication-in-early-life-and-impacts-on-gut-microbiota-and-disease-development
#2
REVIEW
Huan Huang, Jiayin Jiang, Xinyu Wang, Kui Jiang, Hailong Cao
The gut microbiota during early life plays a crucial role in infant development. This microbial-host interaction is also essential for metabolism, immunity, and overall human health in later life. Early-life pharmaceutical exposure, mainly referring to exposure during pregnancy, childbirth, and infancy, may change the structure and function of gut microbiota and affect later human health. In this Review, we describe how healthy gut microbiota is established in early life. We summarise the commonly prescribed medications during early life, including antibiotics, acid suppressant medications and other medications such as antidepressants, analgesics and steroid hormones, and discuss how these medication-induced changes in gut microbiota are involved in the pathological process of diseases, including infections, inflammatory bowel disease, metabolic diseases, allergic diseases and neurodevelopmental disorders...
February 2024: EClinicalMedicine
https://read.qxmd.com/read/38262525/potential-therapeutic-effects-of-chinese-herbal-medicine-in-postpartum-depression-mechanisms-and-future-directions
#3
REVIEW
Hongxiao Xie, Zhiqiang Xie, Fei Luan, Jiuseng Zeng, Xiumeng Zhang, Li Chen, Nan Zeng, Rong Liu
ETHNOPHARMACOLOGICAL RELEVANCE: Postpartum depression (PPD) is a common psychiatric disorder in women after childbirth. Per data from epidemiologic studies, PPD affects about 5%-26.32% of postpartum mothers worldwide. Biological factors underlying this condition are multiple and complex and have received extensive inquiries for the roles they play in PPD. Chinese herbal medicine (CHM), which is widely used as a complementary and alternative therapy for neurological disorders, possesses multi-component, multi-target, multi-access, and low side effect therapeutic characteristics...
January 21, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38057297/gut-liver-brain-axis-in-diseases-the-implications-for-therapeutic-interventions
#4
REVIEW
Mengyao Yan, Shuli Man, Benyue Sun, Long Ma, Lanping Guo, Luqi Huang, Wenyuan Gao
Gut-liver-brain axis is a three-way highway of information interaction system among the gastrointestinal tract, liver, and nervous systems. In the past few decades, breakthrough progress has been made in the gut liver brain axis, mainly through understanding its formation mechanism and increasing treatment strategies. In this review, we discuss various complex networks including barrier permeability, gut hormones, gut microbial metabolites, vagus nerve, neurotransmitters, immunity, brain toxic metabolites, β-amyloid (Aβ) metabolism, and epigenetic regulation in the gut-liver-brain axis...
December 6, 2023: Signal Transduction and Targeted Therapy
https://read.qxmd.com/read/37839699/patterns-of-psychotropic-medication-prescribing-and-potential-drug-hormone-interactions-among-transgender-and-gender-diverse-adults-within-2%C3%A2-years-of-hormone-therapy
#5
JOURNAL ARTICLE
Alin Kalayjian, Kaeleb Laszlo, Molly Fassler, Zachary Schonrock, Kikka E Delarose, Andrew M Ly, Clayton D English, Lauren R Cirrincione
BACKGROUND: Transgender and gender-diverse (TGD) people have a high prevalence of psychotropic medication use, yet knowledge about the patient-level psychotropic medication burden is limited. TGD patients may take hormone therapy to meet their gender expression goals. Potential drug-hormone interactions exist between psychotropic medications and hormone therapy, requiring increased knowledge about psychotropic medication use for TGD adults undergoing hormone therapy. OBJECTIVES: The objective of this study was to examine the extent of psychotropic medication polypharmacy in a cohort of TGD adults within 2 years of starting hormone therapy...
October 13, 2023: Journal of the American Pharmacists Association: JAPhA
https://read.qxmd.com/read/36722239/bromophenols-from-symphyocladia-latiuscula-harvey-yamada-as-novel-cholecystokinin-2-receptor-antagonists
#6
JOURNAL ARTICLE
Pradeep Paudel, Se Eun Park, Su Hui Seong, Fazlin Mohd Fauzi, Hyun Ah Jung, Jae Sue Choi
BACKGROUND: Cholecystokinin (CCK) is one of the most abundant peptides in the central nervous system and is believed to function as a neurotransmitter as well as a gut hormone with an inverse correlation of its level to anxiety and depression. Therefore, CCK receptors (CCKRs) could be a relevant target for novel antidepressant therapy. METHODS: In silico target prediction was first employed to predict the probability of the bromophenols interacting with key protein targets based on a model trained on known bioactivity data and chemical similarity considerations...
January 5, 2023: Journal of Integrative Neuroscience
https://read.qxmd.com/read/34978929/cannabis-use-for-endometriosis-clinical-and-legal-challenges-in-australia-and-new-zealand
#7
JOURNAL ARTICLE
Justin Sinclair, Yasmine Toufaili, Sarah Gock, Amanda G Pegorer, Jordan Wattle, Martin Franke, Muayed A K M Alzwayid, Jason Abbott, David W Pate, Jerome Sarris, Mike Armour
Introduction: Endometriosis is a difficult to manage condition associated with a significant disease burden. High levels of illicit cannabis use for therapeutic purposes have been previously reported by endometriosis patients in Australia and New Zealand (NZ). Although access to legal medicinal cannabis (MC) is available through medical prescription via multiple federal schemes, significant barriers to patient access remain. Methods: An anonymous cross-sectional online survey was developed and distributed through social media via endometriosis advocacy groups worldwide...
August 2022: Cannabis and Cannabinoid Research
https://read.qxmd.com/read/34973081/efficacy-and-safety-of-esketamine-nasal-spray-by-sex-in-patients-with-treatment-resistant-depression-findings-from-short-term-randomized-controlled-trials
#8
JOURNAL ARTICLE
Robyn R Jones, Marlene P Freeman, Susan G Kornstein, Kimberly Cooper, Ella J Daly, Carla M Canuso, Susan Nicholson
The objective of this analysis was to determine if there are sex differences with esketamine for treatment-resistant depression (TRD). Post hoc analyses of three randomized, controlled studies of esketamine in patients with TRD (TRANSFORM-1, TRANSFORM-2 [18-64 years], TRANSFORM-3 [≥ 65 years]) were performed. In each 4-week study, adults with TRD were randomized to esketamine or placebo nasal spray, each with a newly initiated oral antidepressant. Change from baseline to day 28 in Montgomery-Åsberg Depression Rating Scale (MADRS) total score was assessed by sex in pooled data from TRANSFORM-1/TRANSFORM-2 and separately in data from TRANSFORM-3 using a mixed-effects model for repeated measures...
January 1, 2022: Archives of Women's Mental Health
https://read.qxmd.com/read/34368919/prevalence-of-pre-existing-conditions-relevant-for-adverse-events-and-potential-drug-drug-interactions-associated-with-augmentation-therapies-among-patients-with-treatment-resistant-depression
#9
JOURNAL ARTICLE
Maryia Zhdanava, Swapna Karkare, Dominic Pilon, Kruti Joshi, Carmine Rossi, Laura Morrison, John Sheehan, Patrick Lefebvre, Oliver Lopena, Leslie Citrome
INTRODUCTION: Pre-existing conditions relevant for adverse events (AE) and the potential for drug-drug interactions (DDIs) may limit safe pharmacotherapeutic augmentation options for patients with major depressive disorder (MDD). This concern may be heightened among patients with treatment-resistant depression (TRD), who often have comorbid medical disorders. METHODS: Adults with MDD and ≥ 1 antidepressant claim within the first observed major depressive episode were identified in the MarketScan® Databases...
September 2021: Advances in Therapy
https://read.qxmd.com/read/32990281/antistress-and-antidepressant-properties-of-dapoxetine-and-vortioxetine
#10
JOURNAL ARTICLE
Piotr Ratajczak, Krzysztof Kus, Małgorzata Zielińska-Przyjemska, Beata Skórczewska, Tomasz Zaprutko, Dorota Kopciuch, Anna Paczkowska, Elżbieta Nowakowska
The studies aimed to determine the antidepressant efficacy of single and chronic administration of dapoxetine alone and vortioxetine alone, as well as in the combination of these drugs. An additional objective of the study was to measure the effect of the active substances on the corticosterone level in chronically stressed animals. The study was conducted on male Wistar rats using non‑stressed and stressed groups (chronic restraint stress). The experiment comprised both forced swimming test (immobility time test) and corticosterone level measurement using Corticosterone ELISA Kit...
2020: Acta Neurobiologiae Experimentalis
https://read.qxmd.com/read/32940864/the-placebo-phenomenon-and-the-underlying-mechanisms
#11
REVIEW
P Theodosis-Nobelos, A Filotheidou, C Triantis
The clinical role of the placebo effect is a topic of increasing interest for the scientific community. Focus is shifting from the inert role of placebos in randomized controlled trials (RCTs) to potential effects in clinical applications, since the phenomenon is thought to be inherent in routine clinical practice, affecting therapy success rates. Mediation of the mind-brain-body relationship involves both psychosocial and neurobiological factors, the interaction of which comprises the placebo mechanisms. Psychosocial factors include environmentally induced expectations, reward expectations, and even conditioned responses to certain stimuli...
March 2021: Hormones: International Journal of Endocrinology and Metabolism
https://read.qxmd.com/read/32849818/the-emerging-role-of-sgk1-serum-and-glucocorticoid-regulated-kinase-1-in-major-depressive-disorder-hypothesis-and-mechanisms
#12
REVIEW
Vincenzo Dattilo, Rosario Amato, Nicola Perrotti, Massimo Gennarelli
Major depressive disorder (MDD) is a heterogeneous psychiatric disease characterized by persistent low mood, diminished interests, and impaired cognitive and social functions. The multifactorial etiology of MDD is still largely unknown because of the complex genetic and environmental interactions involved. Therefore, no established mechanism can explain all the aspects of the disease. In this light, an extensive research about the pathophysiology of MDD has been carried out. Several pathogenic hypotheses, such as monoamines deficiency and neurobiological alterations in the stress-responsive system, including the hypothalamic-pituitary-adrenal (HPA) axis and the immune system, have been proposed for MDD...
2020: Frontiers in Genetics
https://read.qxmd.com/read/31688420/corticotropin-releasing-hormone-1-receptor-antagonism-attenuates-chronic-unpredictable-mild-stress-induced-depressive-like-behaviors-in-rats
#13
JOURNAL ARTICLE
Xu-Bo Wang, Yong-Qiang Zhang, Ran-Ran Xue, Zhen-Zhen Yang, Xian-Feng Zhang
Hyperactivity of the hypothalamic-pituitary-adrenal axis and impairment of the central corticotropin-releasing factor system are factors in the pathogenesis of depression. Though several antagonists of the corticotropin-releasing factor 1 receptor were effective in the recognized behavioral tests for antidepressant activity, there is still little information on the potential interactions between corticotropin-releasing factor 1 receptor inhibitors and conventional antidepressant therapy. The aim of our study was to assess the influence of CP154526, a corticotropin-releasing factor 1 receptor blocker, which presented some signs of depression...
October 30, 2019: Neuroreport
https://read.qxmd.com/read/30859144/adiponectin-moderates-antidepressant-treatment-outcome-in-the-combining-medications-to-enhance-depression-outcomes-randomized-clinical-trial
#14
JOURNAL ARTICLE
Jennifer L Furman, Abigail Soyombo, Andrew H Czysz, Manish K Jha, Thomas J Carmody, Brittany L Mason, Philipp E Scherer, Madhukar H Trivedi
Background: Major depressive disorder (MDD) is often comorbid with metabolic diseases such as obesity, cardiovascular disease, and type 2 diabetes. A potential link between these disorders is adiponectin, an adipocyte-derived circulating hormone with insulin-sensitizing, anti-inflammatory, and neuroplasticity effects. Reductions in plasma levels of adiponectin have been reported in both humans with depression and in the chronic-defeat mouse model of depression. However, the predictive value of adiponectin for treatment response to depression has not been determined...
August 2018: Personalized Medicine in Psychiatry
https://read.qxmd.com/read/30292827/effects-of-ovarian-hormones-on-emotional-behaviors-in-dopamine-d3-receptor-knockout-mice
#15
JOURNAL ARTICLE
Kedong Xu, Pingping Li, Yi Miao, Nan Dong, Jianbo Zhang, Shuguang Wei, Shengbin Li, Fang Cao
Ovarian hormones reportedly have beneficial effects on affective behaviors. However, the functions of ovarian hormones in neurotransmitter signaling must be identified to understand their role in anxiety and depression. Several studies have provided evidence of the relationship between ovarian hormones and the dopaminergic system, but the interaction between ovarian hormones and dopamine D3 receptor (DRD3) is poorly understood. The aim of the present study was to examine the role of DRD3 in the anxiety-like and depression-like behavioral changes induced by estrogen and progesterone...
October 4, 2018: Physiology & Behavior
https://read.qxmd.com/read/30194544/other-antidepressants
#16
JOURNAL ARTICLE
T E Schwasinger-Schmidt, M Macaluso
This chapter addresses the following FDA-approved medications for the treatment of major depressive disorder available for use in the United States including bupropion, mirtazapine, trazodone, vortioxetine, and vilazodone. These medications do not belong to one of the previously featured classes of antidepressants discussed in the preceding chapters. Each medication featured in this chapter has a unique structure and properties that target diverse receptors in the central nervous system. These diverse targets are distinct from other classes of medications used to treat major depressive disorder...
2019: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/29763648/autism-spectrum-disorder-classification-diagnosis-and-therapy
#17
REVIEW
Samata R Sharma, Xenia Gonda, Frank I Tarazi
Autism Spectrum Disorder (ASD) refers to a group of neurodevelopmental disorders including autism, Asperger's syndrome (AS) and pervasive developmental disorder-not otherwise specified (PDD-NOS). The new diagnostic criteria of ASD focuses on two core domains: social communication impairment and restricted interests/repetitive behaviors. The prevalence of ASD has been steadily increasing over the past two decades, with current estimates reaching up to 1 in 36 children. Hereditary factors, parental history of psychiatric disorders, pre-term births, and fetal exposure to psychotropic drugs or insecticides have all been linked to higher risk of ASD...
October 2018: Pharmacology & Therapeutics
https://read.qxmd.com/read/27756833/the-frontal-cortex-as-a-network-hub-controlling-mood-and-cognition-probing-its-neurochemical-substrates-for-improved-therapy-of-psychiatric-and-neurological-disorders
#18
REVIEW
Mark J Millan, Jean-Michel Rivet, Alain Gobert
The highly-interconnected and neurochemically-rich frontal cortex plays a crucial role in the regulation of mood and cognition, domains disrupted in depression and other central nervous system disorders, and it is an important site of action for their therapeutic control. For improving our understanding of the function and dysfunction of the frontal cortex, and for identifying improved treatments, quantification of extracellular pools of neuromodulators by microdialysis in freely-moving rodents has proven indispensable...
November 2016: Journal of Psychopharmacology
https://read.qxmd.com/read/27677719/botanicals-and-their-bioactive-phytochemicals-for-women-s-health
#19
REVIEW
Birgit M Dietz, Atieh Hajirahimkhan, Tareisha L Dunlap, Judy L Bolton
Botanical dietary supplements are increasingly popular for women's health, particularly for older women. The specific botanicals women take vary as a function of age. Younger women will use botanicals for urinary tract infections, especially Vaccinium macrocarpon (cranberry), where there is evidence for efficacy. Botanical dietary supplements for premenstrual syndrome (PMS) are less commonly used, and rigorous clinical trials have not been done. Some examples include Vitex agnus-castus (chasteberry), Angelica sinensis (dong quai), Viburnum opulus/prunifolium (cramp bark and black haw), and Zingiber officinale (ginger)...
October 2016: Pharmacological Reviews
https://read.qxmd.com/read/25127084/effect-of-restorative-yoga-vs-stretching-on-diurnal-cortisol-dynamics-and-psychosocial-outcomes-in-individuals-with-the-metabolic-syndrome-the-prysms-randomized-controlled-trial
#20
RANDOMIZED CONTROLLED TRIAL
Sarah M Corey, Elissa Epel, Michael Schembri, Sarah B Pawlowsky, Roger J Cole, Maria Rosario G Araneta, Elizabeth Barrett-Connor, Alka M Kanaya
PURPOSE: Chronic stimulation and dysregulation of the neuroendocrine system by stress may cause metabolic abnormalities. We estimated how much cortisol and psychosocial outcomes improved with a restorative yoga (relaxation) versus a low impact stretching intervention for individuals with the metabolic syndrome. METHODS: We conducted a 1-year multi-center randomized controlled trial (6-month intervention and 6-month maintenance phase) of restorative yoga vs. stretching...
November 2014: Psychoneuroendocrinology
keyword
keyword
85147
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.